3M Company
Overview
3M Drug Delivery Systems is a subsidiary of 3M Company, focusing on the innovation and development of advanced drug delivery technologies. The company provides expertise in inhalation, transdermal, and microstructured transdermal systems to enhance the effectiveness and safety of medications.
Therapeutic areas
API / Drug Master Files
3M Company holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- FLURANDRENOLIDE DRUG-IN-ADHESIVE R-2813Active2024-01-17
FDA compliance signals
22 FDA enforcement records linked to this company.
- 4832024-09-06
Valid stability test methods
- 4832024-09-06
Computer control of master formula records
- 4832020-03-20
Calibration/Inspection/Checking not done
- 4832020-03-20
Procedures not in writing, fully followed
- 4832020-03-20
Written distribution procedure
- 4832020-03-20
Contamination, chemical or physical change, deterioration
- 4832019-02-11
Failure to report non-alert ADEs
- 4832018-05-25
Procedures not in writing, fully followed
- 4832018-05-25
Component identity verification
- 4832018-05-25
input/output verification
- 4832018-05-25
Complete Test Data
- 4832017-05-17
Late submission of annual safety reports
- 4832017-05-17
Timing of AE report submission (non-RX drugs)
- 4832017-05-17
Form FDA 2252
- 4832017-05-17
New medical information, timing of submission (non-Rx drugs)
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.